Supply of Multiplex Fluorescence Scanner to Public Health England for Research Department, Porton

About

Public Health England awarded a contract to Akoya Biosciences Inc.

for the purchase of a multiplex fluorescence slide scanner with quantitative pathology imaging and analysis, valued at £425,000, to be used in the Research Department at Porton.

The system enables quantitative multiplex image analysis with artificial intelligence applications in pathology, including tissue classification, phenotyping, and pattern recognition, and includes automated algorithms to eliminate autofluorescence in tissue slides.

It supports ongoing and future research on high-priority infectious diseases such as COVID-19, Ebola, Zika, Crimean Congo Haemorrhagic Fever, Chikungunya, Q Fever, Anthrax, Melioidosis, Clostridium difficile-Associated Disease, Tuberculosis, Monkeypox, Influenza, Pertussis, Meningococcal disease, Group B Streptococcal disease, Legionnaires Disease, Healthcare Acquired Infections, and Anti-Microbial Resistance.

The workstation also scans conventional brightfield stained slides and produces digital H&E e-slides from fluorescence-stained slides, increasing resilience and reducing laboratory workload.